Bionoid Pharma Inc.
BINP
$0.08
$0.000.00%
OTC PK
| 03/31/2012 | 03/31/2011 | ||||
|---|---|---|---|---|---|
| Net Income | 89.65% | -1,055.39% | |||
| Total Depreciation and Amortization | -9.76% | -9.89% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | -88.32% | 2,822.45% | |||
| Change in Net Operating Assets | -92.90% | 61.67% | |||
| Cash from Operations | 100.09% | -156.16% | |||
| Capital Expenditure | -- | 94.44% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -- | 94.44% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | -- | -116.00% | |||
| Foreign Exchange rate Adjustments | -126.09% | -45.24% | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 99.99% | -409.63% | |||